{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:42:35Z","timestamp":1781664155054,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10072-020-04388-4","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T20:02:21Z","timestamp":1587240141000},"page":"2819-2824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Aspirin or anticoagulation after cryptogenic stroke with patent foramen ovale: systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"41","author":[{"given":"Michele","family":"Romoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Giannandrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Eusebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia M.","family":"Cupini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,18]]},"reference":[{"key":"4388_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(18)30167-4","volume":"17","author":"S Mazzucco","year":"2018","unstructured":"Mazzucco S, Li L, Binney L, Rothwell PM (2018) Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis. Lancet Neurol 17:609\u2013617. https:\/\/doi.org\/10.1016\/S1474-4422(18)30167-4","journal-title":"Lancet Neurol"},{"key":"4388_CR2","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","volume":"36","author":"DM Kent","year":"2015","unstructured":"Kent DM, Dahabreh IJ, Ruthazer R et al (2015) Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis. Eur Heart J 36:2381\u20132389. https:\/\/doi.org\/10.1093\/eurheartj\/ehv252","journal-title":"Eur Heart J"},{"key":"4388_CR3","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","volume":"380","author":"H-C Diener","year":"2019","unstructured":"Diener H-C, Sacco RL, Easton JD et al (2019) Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med 380:1906\u20131917. https:\/\/doi.org\/10.1056\/NEJMoa1813959","journal-title":"N Engl J Med"},{"key":"4388_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1474-4422(18)30319-3","volume":"4422","author":"SE Kasner","year":"2018","unstructured":"Kasner SE, Swaminathan B, Lavados P et al (2018) Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol 4422:1\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(18)30319-3","journal-title":"Lancet Neurol"},{"key":"4388_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12872-018-0780-x","volume":"18","author":"X-L Zhang","year":"2018","unstructured":"Zhang X-L, Kang L-N, Wang L, Xu B (2018) Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis. BMC Cardiovasc Disord 18:45. https:\/\/doi.org\/10.1186\/s12872-018-0780-x","journal-title":"BMC Cardiovasc Disord"},{"key":"4388_CR6","doi-asserted-by":"publisher","unstructured":"Sagris D, Georgiopoulos G, Perlepe K et al Antithrombotic treatment in cryptogenic stroke patients with patent foramen ovale: systematic review and meta-analysis. Stroke. https:\/\/doi.org\/10.1161\/STROKEAHA.119.026512","DOI":"10.1161\/STROKEAHA.119.026512"},{"key":"4388_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","volume":"81","author":"DM Kent","year":"2013","unstructured":"Kent DM, Ruthazer R, Weimar C et al (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81:619\u2013625. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a08d59","journal-title":"Neurology"},{"key":"4388_CR8","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","volume":"89","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther 89:873\u2013880","journal-title":"Phys Ther"},{"key":"4388_CR9","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928\u2013d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"4388_CR10","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE et al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092\u20131100. https:\/\/doi.org\/10.1056\/NEJMoa1301440","journal-title":"N Engl J Med"},{"key":"4388_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J et al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991\u2013999. https:\/\/doi.org\/10.1056\/NEJMoa1009639","journal-title":"N Engl J Med"},{"key":"4388_CR12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP et al (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 368:1083\u20131091. https:\/\/doi.org\/10.1056\/NEJMoa1211716","journal-title":"N Engl J Med"},{"key":"4388_CR13","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","volume":"105","author":"S Homma","year":"2002","unstructured":"Homma S, Sacco RL, Di Tullio MR et al (2002) Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 105:2625\u20132631. https:\/\/doi.org\/10.1161\/01.CIR.0000017498.88393.44","journal-title":"Circulation"},{"key":"4388_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1378\/chest.124.5.1924","volume":"18","author":"A Shariat","year":"2013","unstructured":"Shariat A, Yaghoubi E, Farazdaghi M et al (2013) Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial. J Res Med Sci 18:94\u201398. https:\/\/doi.org\/10.1378\/chest.124.5.1924","journal-title":"J Res Med Sci"},{"key":"4388_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"J-L Mas","year":"2017","unstructured":"Mas J-L, Derumeaux G, Guillon B et al (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 377:1011\u20131021. https:\/\/doi.org\/10.1056\/NEJMoa1705915","journal-title":"N Engl J Med"},{"key":"4388_CR16","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1161\/STROKEAHA.119.028325","volume":"380","author":"M Romoli","year":"2019","unstructured":"Romoli M (2019) Letter by Romoli regarding article, \u201cAntithrombotic treatment in cryptogenic stroke patients with patent foramen ovale: systematic review and meta-analysis.\u201d. Stroke 380:1906\u20131917. https:\/\/doi.org\/10.1161\/STROKEAHA.119.028325","journal-title":"Stroke"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04388-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T23:48:54Z","timestamp":1618703334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04388-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,18]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4388"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04388-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,18]]},"assertion":[{"value":"1 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}